CYTOMEGALOVIRUS INFECTIONS

Clinical trials for CYTOMEGALOVIRUS INFECTIONS explained in plain language.

Never miss a new study

Get alerted when new CYTOMEGALOVIRUS INFECTIONS trials appear

Sign up with your email to follow new studies for CYTOMEGALOVIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 2 Not yet finished but already full! 2 Completed 7 Terminated 1

New approach to stop deadly virus in vulnerable transplant patients

Disease control Terminated

This study tested whether a special antibody treatment (Cytotect®CP) could safely prevent dangerous cytomegalovirus (CMV) infections in patients who had received a stem cell transplant and developed graft-versus-host disease (GVHD). The trial focused on patients at very high risk…

Matched conditions: CYTOMEGALOVIRUS INFECTIONS

Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control

Last updated Apr 02, 2026 02:23 UTC

CYTOMEGALOVIRUS INFECTIONS

Get alerted when new CYTOMEGALOVIRUS INFECTIONS trials appear

New approach to stop deadly virus in vulnerable transplant patients